BioTek launches the new Epoch™ 2 Microplate Spectrophotometer

BioTek proudly unveils the new Epoch™ 2 Microplate Spectrophotometer. Epoch 2 is the first reader to combine a large touchscreen and full onboard data analysis software for simplified and efficient operation and reporting of absorbance-based detection workflows.

The 10-inch color touch screen interface offers an enhanced user experience, with intuitive navigation and a high resolution display. On-board Gen5™ Data Analysis Software provides quick analysis and flexible export and report options at the touch of a few buttons. Data export is expanded via WiFi, Bluetooth^® and USB flash drive.

To further maximize versatility, Epoch 2 features a spectral range from 200 to 999 nm, selectable in 1 nm increments for single, dual and multi-wavelength measurements in endpoint and kinetic read methods; and also offers spectral scanning and well area scanning. Compatible sample vessels include 6- to 384-well microplates, standard cuvettes and 2 μL micro-volume samples via BioTek's Take3™ Micro-Volume Plates. Standard linear, orbital and double orbital shaking, and precise 4-Zone™ temperature control to 65 °C are ideal for cell-based assays. Throughput may be increased by interfacing with BioTek's BioStack™ Microplate Stacker or third-party automation.

BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. These technologies are used to aid life science research, facilitate drug discovery, provide rapid and cost-effective analysis, and enable sensitive, accurate quantification of molecules across diverse applications. BioTek espouses a "Think Possible" approach that sets the tone for fresh ideas, unsurpassed customer service and original innovations. As such, they are often honored for local accomplishments and technological innovations, including Best Places to Work in Vermont, Frost & Sullivan North American New Product Innovation Award for Workflow Solutions in Life Sciences, SelectScience's Drug Discovery Product of the Year – Scientists' Choice Award, and a Silver Edison Award for the Cytation Cell Imaging Multi-Mode Reader.